Sunday 29 January 2023

Week 390 Review - Probiotix shares collapse 57% when lock-in ends losing £12k in portfolio value

This would have been a relatively flat week, but the big sell-off started as people started getting access to their free PBX:Probiotix shares. My decision to take a small loss and sell for 20p a few weeks ago was vindicated as the price slumped to 8p, more than halving the value of my dividend holding which I'm still not free to sell. I won't be selling - I'll be buying, but only after the price crashes even more as the main brokers make the shares available.

My deficit between cost and value widened by a massive £12,786 to a record £128,253, with portfolio value at £68,306. I'm not worried about this drop though, as it was entirely predictable and will hopefully just be a short-lived buying opportunity, and I have plenty of ammo waiting for the right moment.

PBX:Probiotix Health dropped 57% in a week - pretty spectacular, and given my holding was worth £20k explains most of the drop this week.

POLY:Polymetal dropped 9% of my original purchase price, but more like 40% from its price last week after fears that they will be screwed out of their Russian assets, and worry about them domiciling in Kazakhstan. I'm stuck with these as they've dropped so much, so resigned to whatever fate befalls them.

A couple of my new purchases dropped more than 5%, but that's mainly due to spread and commission. They did fall in price too. SHG:Shanta Gold dropped 9% and CAPD:Capital dropped 6%, but it's early days for these.

NUM:Numis Corp has been recovering lately, but dropped 6% this week. This is the share I should have sold when they went past my 15% threshold, but I missed the chance and now they are 26% down so I won't sell. Hoping for a recovery though.

BLU:Blue Star Capital climbed 8% on no news, so I suspect something must be going on that we don't know about. I don't really care what happens with these as it's a tiny investment.

Share of the week is III:3i Group which climbed 11%. The only problem is these are my monthly savings shares and I only have £250 of them so far, so the 11% was about £27.

I've done away with the cumulative chart, as I figure it's so similar to the others I may as well not show it. I've also combined the share listing for the ISA and share accounts in the right column as they're in the same spreadsheet and chart, and I added a load of cash into my new AJ Bell account while I wait until April when I can transfer it to an ISA.

Here's the ISA and shares portfolio after week 26 of year 8.




Weekly Change
Cash £4,037.00

+£4,007.77
Portfolio cost £90,161.49
+£4,992.23
Portfolio sell value (bid price-commission) £27,135.50 (-69.9%) -£6,406.60
Potential profits £0
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.09
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£169.05 (-3.6%) +£6.75
Total Dividends £11,768.92
+£0
Total Interest £0.09
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £428.02
(9.1%) -£1.10
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 68% -13%

I added loads of cash from my pension lump sum, almost £5,000 of which went on shares and the rest is ammo for PBX:Probiotix bargains, although not all of it.

Portfolio value dropped by £6,406 almost entirely because of PBX:Probiotix, and long term performance dropped by over 1% due to the big increase in injection amount.

The first new share I bought was ASHM:Ashmore Group. I held them in the past but sold due to concerns over their exposure to Evergrande. That seems to have blown over now China has lifted Covid restrictions so I bought back in. I got 364 shares at 270.301p costing £998.77 with commission and stamp duty. They dropped 1p so are down by 3% with spread and commission.

The next new share was WHR:Warehouse REIT which has been near the top of my magic formula ranking for a while. I bought 910 shares at 108.1783p costing £999.29. They rose to 108.6p but are down 2% on commission.

The next new share was PAGE:Page Group, which again are high on my magic formula ranking. They are a recruitment agency so seem to be out of favour due to possibility of recession, but it seems to me we have a workforce shortage, so their services are likely to still be in demand. I bought 217 shares at 452.32p costing £996.39. They dropped slightly to 449.8p so are down 3%.

The next new share wasn't originally on my magic formula spreadsheet, but I read an article about them and they looked interesting. When I added them to the spreadsheet they came in the top 30 so qualify as a magic formula share. They are CAPD:Capital and provide contract services in a range of industries. I bought 917 shares at 107.87p costing £999,12. They dropped to 103p so are down 6% when you include commission.

The final share was an old favourite. Not a magic formula share, but one I've kept an eye on since owning them a few years ago. CWR:Ceres Power are still loss-making, but they should be signing a joint venture in China very soon which should see them generate a lot more revenue. I've made £1,500 profit from previous holdings so thought they were worth a bit of risk. I bought 238 shares at 415.425p costing £998.66. They rose to 423.6p but are still just down by 44p due to commission.

So quite an exciting week for new purchases, and a hope that this account may finally get to register some profitable shares soon.


Big up-tick in cost and injection lines, but much lower up-tick in value.


That says it all, with a plummet back below the trend line.

The SIPP looks like this after week 374 overall and week 10 of year 8.




Weekly Change
Cash £130.52
+£0
Portfolio cost £99,361.09
+£0
Portfolio sell value
(bid price - commission)
£35,480.53 (-64.3%) -£6,303.47
Potential profits £1,114.98
+£104.40
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.33
+£0
Yr 8 Profit from sales -£67.32
+£0
Yr 8 projected avg monthly profit -£39.09 (-0.8%) +£4.35
Total Dividends £14,142.78
+£0
Total Interest £0.58
+£0
Total Profit from sales £20,366.43
+£0
Average monthly cash profit £388.03 (7.8%) -£1.04
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 56% +0%

Very little happened apart from the PBX:Probiotix crash, and most of last week's reduction in potential profit was clawed back. IGG:IG Group are getting perilously close to the 15% loss when I should sell them, down by 11%. They have been down way below 15% in the past and come back almost to profit, but are not performing very well. Having said that, the dividend has been very good returning 9% altogether in the 2 years I've held them.


New record low


Back below the trend line as we spiral ever lower. This is all down to microbiome shares. If they don't turn around soon I'm doomed. I'm convinced they will turn around, but I've been known to be wrong.

The trading account looks like this after week 340 overall and week 28 of year 7.




Weekly Change
Cash £20.31
+£10.21
Portfolio cost £2,849.00
+£999.79
Portfolio sell value (bid price - commission) £1,502.15 (-47.3%) -£76.25
Potential profits £0
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£11.10 (-4.7%) +£0.41
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.74 (1.2%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)

I added £1,000 injection to try and kick start the account, as it's all gone horribly wrong. The shares promptly lost £76 so it continues to go horribly wrong.

I bought 3948 shares in JLP:Jubilee Metals at 12.41p because I was convinced they'd go up as soon as the warrant seller stopped. I was wrong, although offer price is now above what I paid, but with wide spread they are down 5%.

I also bought 4145 shares in SHG:Shanta Gold which is another of my old holdings and one I expected to go up as the price of gold goes up, but the share price dropped and there's a wide spread, so they are already down 9%.

The problem with only spending £500 is the commission takes up 4%, so when there's a big spread it takes a lot of effort to make that up. I may have to re-think and switch to £1,000 as minimum investment, although on past performance that would just help me lose twice as much money.


Everybody up!


The real truth - dropping for 6 months and below the trend line. Will it turn around with the new blood?

It feels like a bit of a fresh start having injected loads of new money and bought more magic formula shares. I still have £4k to spend in my new share account, at least £2k of which will be PBX:Probiotix, and I also have £2k more coming from my work pension transfer. I'm very tempted to use that to buy more CAML:Central Asia Metals, as they have paid off all their debt, so unless they have another acquisition in mind, they may have to dish some of it out to shareholders. It's quite revealing that there's no longer even the slightest temptation to buy any more OPTI:Optibiotix!

Saturday 21 January 2023

Week 389 Review - A flat week, but a big new injection of cash boosts the morale

A very flat week, but lots of exciting developments and an influx of cash on the way. There was a slight improvement in the deficit between cost and value of £681, bringing it down to £115,467 and overall portfolio value increased to £71,082.

Biggest loser was CEY:Centamin dropping 7%, which was a surprise given their positive production update. They have zero debt and a massive pile of cash, so I'm happy to continue holding them for the attractive dividend, which has paid out 8% since I bought them. Unfortunately the big drop took them out of profit to 2% loss. I'll apply the maximum 15% loss rule to them now, but hope they will get back into profit next week.

I bought back into JLP:Jubilee Metals as the final warrants have been exercised so I'm hoping the selling will slow down now the warrant holders have raised cash to buy the rest of their allocation. Unfortunately the spread and commission mean that one of my holdings is already down 7%, but another one is only down by 1%. I'm expecting a rapid rise to 20p, especially if there's news on copper production.
Share of the week was SBTX:SkinBioTherapeutics which climbed 11% for no apparent reason. There's thoughts that an announcement from Croda may be imminent, or people are just getting twitchy. The 11% rise means my holding is only 49% down, so has changed colour from crimson to orangered. Hope that trend continues.


Note that everything has ticked up - more on that soon...


An almost flat week, but still just above the trend line

Here's the ISA and shares portfolio after week 25 of year 8.




Weekly Change
Cash £29.23

+£14.03
Portfolio cost £85,169.26
+£3,006.01
Portfolio sell value (bid price-commission) £28,549.87 (-66.5%) +£266.58
Potential profits £0
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.09
+£0.04
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£175.81 (-4.4%) +£7.33
Total Dividends £11,768.92
+£0
Total Interest £0.09
+£0.04
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £429.12
(10.8%) -£1.11
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 81% -6%

I added £3,000 to my ISA after receiving my pension lump sum. The majority has gone into premium bonds, as I need to live off it now I'm dropping to working a 4-day week, but I want to put some in my ISA. I'm concerned that too much of my holding is with Hargreaves Lansdown so want to spread my risk a little, but as I already have an ISA open with them this year, I can't open another one with someone else. It's nearly April, so I've stashed £10k in a savings account and will open an ISA with AJ Bell in April, although if an irresistible bargain comes along before then I may put a little more into Hargreaves Lansdown.

I used the cash to buy 15,678 shares in JLP:Jubilee Metals at 12.68p costing £1,999.92 and 54 shares in PLUS:Plus 500 at 1841p costing £1,006.09.

Both are shares I have owned in the past and I didn't want to sell PLUS:Plus 500. I got stopped out when they dropped 10%, but made £97 profit and £73 dividend, and they have so much cash that I feel a special dividend could be on the cards in February and I want to be invested when that happens.

OPTI:Optibiotix went up by 0.25p which explains the small increase in value of £266 in an otherwise fairly flat week, and 4p interest is a sign that higher interest rates are making having some cash more attractive.

The big increase in injection amount caused cumulative performance to drop by 6% and long term average performance to drop by 0.8%.


Nice to see a big tick up, but not nice that the gap between value and injection amount is still just as wide.


Similar to overall chart.

The SIPP looks like this after week 373 overall and week 9 of year 8.




Weekly Change
Cash £130.52
-£1,600.47
Portfolio cost £99,361.09
+£1,899.89
Portfolio sell value
(bid price - commission)
£41,784.00 (-57.9%) +£408.54
Potential profits £1,010.58
-£114.60
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.33
+£0.11
Yr 8 Profit from sales -£67.32
+£0
Yr 8 projected avg monthly profit -£43.44 (-0.9%) +£5.11
Total Dividends £14,142.78
+£0
Total Interest £0.58
+£0.11
Total Profit from sales £20,366.43
+£0
Average monthly cash profit £389.07 (7.8%) -£1.05
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 56% +0%

I used the money I was saving to buy PBX:Probiotix to buy 15,822 shares in JLP:Jubilee Metals at 11.945p costing £1,899.89. I timed this better than the ISA purchase and they were briefly in profit but dropped back on Friday and are 1% down now. If PBX absolutely tanks, then I'll inject some cash into my ISA to buy some bargains, or possibly sell some JLP if it zooms up next week.

Value is up for the same reason as the ISA, and 11p interest appeared. I could do with selling something just to get the annual profit into positive territory, but we're only on week 9 so there's plenty of time. I've also put in a transfer request for another £2k from my current work pension so that might arrive in time to use for PBX bargains, although I would like to get some new magic formula shares.


Still pretty poor


As with the other charts, just above the trend line

The trading account looks like this after week 339 overall and week 27 of year 7.




Weekly Change
Cash £10.10
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £578.61 (-68.7%) +£6.17
Potential profits £0
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£11.51 (-7.5%) +£0.44
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.75 (1.8%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)

The tiny rise in OPTI:Optibiotix sees this improve a fraction

I just had a thought - I can't open my new ISA until April, but there's nothing stopping me temporarily putting some of it into my standard share account to try and kick start this. I'll add £1k and try and turn around this account's fortunes a bit. If I'm right about JLP:Jubilee Metals then I'm more likely to keep my main holdings for longer if I can trade a smaller amount in here.


There's a long way to go if I am going to turn this mess around


The trend line is getting pulled flat again

There's a storm brewing with PBX:Probiotix, and it's already started. The share price has dropped during the week but I didn't reflect it in my spreadsheet as I don't really know what's going on. It's all over the place with a stupid spread, so I decided to wait until the dividend shares are available for trading and try and reflect the price change then. Unfortunately I'm almost certainly going to show a drop of about £10,000 portfolio value, as it's already showing a bid price of 15p which is a 25% drop, and nobody has received their free shares yet. I think it's going to nose dive next week, which is why I need to be ready to buy, but I have to wait until it's gone as low as it's going to. I'm anticipating less than 10p, as ex-OPTI:Optibiotix shareholders will likely sell at any price. I need to get my timing just right, although I don't have a very good track record for that!

Saturday 14 January 2023

Week 388 Review - An OK week spoiled by Optibiotix losing 1p

This week wasn't as good as last week, but would have been pretty good if OPTI:Optibiotix hadn't lost 1p and blatted all the other gains. The deficit between cost and value widened by £1,708 to £116,148 and overall portfolio value dropped to £67,081.58

OPTI:Optibiotix was the biggest loser, with the trading holdings dropping 5%. So much for them benefiting from a positive PBX:Probiotix update.

ANTO:Antofagasta had another good week, climbing 6% to go back to 19% up and making potential profit of  £193. That means they are back at the highest they have been and gives me back the full 10% buffer to my 9% virtual stop loss.

III:3i Group went up by 8% and are now less than £1 in the red. The increase was exaggerated slightly as I bought my next monthly investment so the selling commission is a smaller percentage of the whole. 

Share of the week is CAML:Central Asia Metals which climbed 8% for the second week in a row and is now 25% up and making £832 potential profit. It seems like ages since I had decent profits to report. My virtual stop loss has risen to 15% so I'm guaranteed to make £500 profit even if they tank and trigger it. I really hope that doesn't happen, as I want to hold these long-term.


I knew it was too good to last


Above the tend line but running parallel to it

Here's the ISA and shares portfolio after week 24 of year 8.




Weekly Change
Cash £15.20

+£0
Portfolio cost £82,163.25
+£0
Portfolio sell value (bid price-commission) £25,277.28 (-69.2%) -£1,017.61
Potential profits £0
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.05
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£183.14 (-4.9%) +£7.97
Total Dividends £11,768.92
+£0
Total Interest £0.05
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £430.23
(11.6%) -£1.11
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

The drop in value was only half the gain I made last week so I feel up on the year


Still grim


Above the trend line - but only just

The SIPP looks like this after week 372 overall and week 8 of year 8.




Weekly Change
Cash £1,730.99
-£126.77
Portfolio cost £97,461.20
+£126.77
Portfolio sell value
(bid price - commission)
£39,475.57 (-59.5%) -£666.58
Potential profits £1,125.18
+£329.41
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.22
+£0.19
Yr 8 Profit from sales -£67.32
+£0
Yr 8 projected avg monthly profit -£48.55 (-1.0%) +£7.06
Total Dividends £14,142.78
+£0
Total Interest £0.47
+£0.19
Total Profit from sales £20,366.43
+£0
Average monthly cash profit £390.12 (7.9%) -£1.05
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 56% +0%

Cash dropped and portfolio cost rose as my monthly investment was processed. I bought 9 shares in III:3i Group at 1385.05p costing £126.77 with commission and stamp duty.. Another 6 months will get me my £1,000 worth so I can switch to something else.

Value dropped a lot less than the ISA because potential profits in magic formula shares went up by £329.  I also found a 19p interest payment.


Much the same as the ISA, but closer to the injection line


A tiny bit more above the trend line than the ISA


The trading account looks like this after week 338 overall and week 26 of year 7.




Weekly Change
Cash £10.10
+£10.00
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £572.44 (-69.0%) -£24.69
Potential profits £0
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£11.95 (-7.8%) +£0.48
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.76 (1.8%) +£0
(Sold stocks profit + Dividends - Fees
/ Months)

I added £10 cash just as a precaution against the ISA or SIPP ever running short when fees are due. I'll just keep it as an emergency pot. Meanwhile all last week's gains in OPTI:Optibiotix were lost.


Dire


Not the worst ever, but below the trend line and clearly on a 6-month downward trend.

There's still no sign of the PBX:Prebiotix shares arriving in my accounts, other than as a dummy line. The lock-in should have ended so I'm expecting them to appear very soon, and when they do the selling will start, so I need to amass as big a fighting fund as I can afford to sweep up bargains. I'll add some more to my AJ Bell SIPP in preparation for the event. Every one more share I can get from the sell-off will be a bonus when they announce profits and start trading on AIM.


Saturday 7 January 2023

Week 387 Review - Great start to the New Year

A really good week, with gains all over the portfolio, lots of 8% gains and a 1p rise in OPTI:Optibiotix. That narrowed the deficit between cost and value by £4,212 to £114,439 and increased portfolio value to £68,780.

There were no big fallers this week.

OPTI:Optibiotix climbed 1p, which is 5% in my trading holdings. It was on the back of a good update from PBX:Probiotix Health which also rose by 5%. However, that wasn't the great news I was hoping for so I sold my purchased holding at a loss so I have ammo for when the share price collapses following the end of the lock-in.

RIO:Rio Tinto is one of my most recent magic formula shares and climbed 5% to go 3% into profit.

TRX:Tissue Regenix was the last of the 5% risers. There was no particular news, but things seem to be improving for them and I'm still hopeful they will eventually become profitable or get bought out.

ANTO:Antofagasta is another recent magic formula purchase and climbed 8% this week to go 13% up altogether, so I can now set a virtual stop loss at 3% to guarantee I don't make a loss. Really hoping it never gets triggered though.

CAML:Central Asia Metals also rose 8% as most of the metal producers had a good week. They are now 17% up and making potential profit of £579, so the virtual stop loss is increased to 7%. 

The last 8% riser was NUM:Numis Corp. These have been desperately disappointing so far, but climbed to a 25% loss so at least went from orange/red to orange in the colour coding.

Share of the Week goes to CEY:Centamin. They have been a bit rubbish for the 18 months or so I've held them, but climbed 11% this week to go into profit by 7%. With an additional 8% in dividends these are now looking much more respectable.


Well, it's a tick up, but can it be sustained?


Above the trend line!

Here's the ISA and shares portfolio after week 23 of year 8.




Weekly Change
Cash £15.20

+£0
Portfolio cost £82,163.25
+£0
Portfolio sell value (bid price-commission) £26,294.89 (-68.0%) +£2,109.33
Potential profits £0
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.05
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£191.11 (-5.2%) +£17.42
Total Dividends £11,768.92
+£0
Total Interest £0.05
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £431.34
(11.6%) -£2.28
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

Pretty quiet, but nice rise of £2,109 in value. I have just over six months to try and make £1,000 profit to overturn the Year 8 deficit.


Doesn't look like a convincing up-tick


Above the trend line but it's going to take some turning around.

The SIPP looks like this after week 371 overall and week 7 of year 8.




Weekly Change
Cash £1,857.76
+£1,513.05
Portfolio cost £97,334.43
-£1,114.44
Portfolio sell value
(bid price - commission)
£40,015.38 (-58.9%) +£1,114.44
Potential profits £795.77
+£452.44
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.03
+£0.02
Yr 8 Profit from sales -£67.32
-£161.73
Yr 8 projected avg monthly profit -£55.61 (-1.1%) -£114.40
Total Dividends £14,142.78
+£0
Total Interest £0.28
+£0.02
Total Profit from sales £20,366.43
-£161.73
Average monthly cash profit £391.17 (7.9%) -£3.07
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 56% -1%

I sold the PBX:Probiotix shares I bought on the market when they went up to 20p. It was 6,740 shares and I made a loss pf £161.73 (-10.8%), but liberated £1,338.05 for when the share price tanks after the lock-in ends and I can buy at least twice as many.

Great increase in potential profits of £452, with CEY:Centamin and RIO:Rio Tinto both going into profit and joining ANTO:Antofagasta and CAML:Central Asia Metals which also had good gains.

The sale rather spoiled my Year 8 performance, sending it negative, but it had to be done to limit my losses from the misguided purchase of PBX on the open market.


Will we ever see those meteoric rises that sent the value back above the injection line twice in the last 12 months?


Need about £20k improvement to flatten the trend line. OPTI:Optibiotix climbing to 40p would do that. Unfortunately DDDD:4D Pharma and PBX:Probiotix are about to absolutely tank and cost me about the same amount.

The trading account looks like this after week 337 overall and week 25 of year 7.




Weekly Change
Cash £0.10
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £597.13 (-67.7%) +£24.69
Potential profits £0
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£12.43 (-8.1%) +£0.52
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.76 (1.8%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)

The 1p increase in OPTI:Optibiotix sees a small rise for the second week. Still a long way from being able to sell. At least there is now some slim hope DDDD:4D Pharma will survive, albeit massively diluted. I'll have to take the loss as it will be a decade before they get back to the purchase price in this account.


Slow and steady - for now...


Tragically still below the trend line

It's very encouraging that the year started so well. I don't know how long it will last, but will enjoy it while I can.